Indications
Therapeutic Asset Ratings
18,135 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Carboplatin
Radiation Injury
Sun Yat-sen University
P3
BB
(67)
Cariprazine
Schizophrenia
Mapi Pharma Ltd.
P3
BB
(67)
Carisbamate
Lennox-Gastaut Syndrome
SK Life Science, Inc.
P3
BB
(67)
Carvedilol
Breast Carcinoma
Mayo Clinic
P3
BB
(67)
Casdatifan
Nonpapillary Renal Cell Carcinoma
Arcus Biosciences, Inc.
P3
BB
(67)
Cediranib
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P3
BB
(67)
Clemizole
Dravet Syndrome
Epygenix
P3
BB
(67)
Clopidogrel
Non-Small Cell Lung Carcinoma
Shanghai Chest Hospital
P3
BB
(67)
Clopidogrel
Patent Foramen Ovale
Chinese Academy of Medical Sciences, Fuwai Hospital
P3
BB
(67)
Crinecerfont
Congenital Adrenal Hyperplasia
Neurocrine Biosciences
P3
BB
(67)
Cyclophosphamide
Metastatic Malignant Neoplasm In The Lymph Nodes
Laura M. Spring, MD
P3
BB
(67)
Cyclophosphamide
Central Nervous System Leukemia
Masonic Cancer Center, University of Minnesota
P3
BB
(67)
Cyclophosphamide
Down Syndrome
National Cancer Institute (NCI)
P3
BB
(67)
Cyclophosphamide
Idiopathic Pulmonary Fibrosis
Paul Szabolcs
P3
BB
(67)
Cyclophosphamide
Chronic Progressive Multiple Sclerosis
Bruce Cree
P3
BB
(67)
Cyclophosphamide
Myeloid Sarcoma
St. Jude Children's Research Hospital
P3
BB
(67)
Dacarbazine
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)
P3
BB
(67)
Dacarbazine
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(67)
Dacarbazine
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)
P3
BB
(67)
Dacarbazine
Hodgkin'S Lymphoma, Lymphocytic-Histiocytic Predominance
National Cancer Institute (NCI)
P3
BB
(67)
Dacarbazine
Soft Tissue Sarcoma
Institut Bergonié
P3
BB
(67)
Dapagliflozin
Heart Failure
University Medical Centre Ljubljana
P3
BB
(67)
Daunomycin
Down Syndrome
National Hospital Organization Nagoya Medical Center
P3
BB
(67)
Daunomycin
Myeloproliferative Neoplasm
Children's Oncology Group
P3
BB
(67)
Daunomycin
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology Group
P3
BB
(67)
Showing 3126 to 3150 of 18,135 assets
Previous
Page 126 of 726
Next